JEREMY GUNTER: Open Payments
NPI 1285198150 · SOUTH BEND, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,624 in 106 payments from 25 companies in 2025. Trend: 2023 $3,002 · 2024 $3,649 · 2025 $1,624
Food & beverage: $1,579Education: $45
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 14 | $217 |
| ABBVIE INC. | 16 | $201 |
| AstraZeneca Pharmaceuticals LP | 11 | $190 |
| Axsome Therapeutics, Inc. | 9 | $167 |
| PFIZER INC. | 11 | $145 |
| Novo Nordisk Inc | 11 | $136 |
| Lundbeck LLC | 4 | $86 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $44 |
| GlaxoSmithKline, LLC. | 3 | $44 |
| Abbott Laboratories | 2 | $42 |
Products named: FARXIGA, Auvelity, QULIPTA, JARDIANCE, REXULTI, VRAYLAR, Ozempic, NURTEC ODT.
Industry payments across IN — which companies pay providers there.
